Unveiled: Reasons Bortezomib Would Make You More Happy

Significantly, the ERSPC study reported no deaths as a direct complication (septicaemia or bleeding) of a prostate biopsy [4] in 17?543 biopsies performed in seven European countries. Whilst http://www.selleck.cn/products/blu9931.html the primary aim of the ERSPC was to determine prostate cancer mortality, all causes of death were critically evaluated in a ��blinded�� fashion and according to a standard algorithm or, a validated official cause of death [5]. Why the authors used the prostate cancer mortality rates from the ERSPC but not the biopsy mortality rate of zero is very confusing. Another recent large study of 75?190 men undergoing transrectal prostate biopsy has also reported a far lower mortality rate of 0.09% [6]. Overall, the benefit of PSA screening remains controversial. It is possible that the authors chose a favourable study with a higher than normal prostate biopsy mortality to make their statistical point clearer. We know that transrectal prostate biopsy is dangerous and population screening remains unproven. However, we do feel that one has to be cautious in the subsequent retrospective application of favourable statistics in one paper to other unrelated larger studies. The public does not need to be further confused and alarmed over the PSA debate, as indications are that longer term follow-up of the ERSPC will show an increasingly http://www.selleckchem.com/products/Bortezomib.html strong stance for PSA screening saving lives [7]. ""I am grateful for Dr Abdollah's and his co-writers�� reply to my previous letter [1] about their article reporting on the proportion of lymph node metastases (LNM) detected by pelvic lymph node dissection (PLND) among 1520 patients with prostate cancer [2]. However, in their reply they believe that http://www.selleckchem.com/products/gsk1120212-jtp-74057.html I have misinterpreted the results of the study. I still do not think I have. They correctly state that 19% of the patients had LNM above the 7% threshold of predicted risk, but that was not my point. According to Table 2, 17 patients with a predicted risk of LNM